Showing results (341-350 of 1,136) with videos related to
Sort By:
Pageof 114
Trends in Parasitology|January 5, 2002
Call to consolidate achievements for onchocerciasis and lymphatic filariasis controlA Hoerauf, R D Walter, H Remme, et al.The Journal of Dermatological Treatment|October 14, 2009
Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?Rajesh Balkrishnan, Monali J Bhosle, Alan B Fleischer, et al.Dermatology Online Journal|March 18, 2003
A systematic review of adverse effects associated with topical treatments for psoriasisChristine R Bruner, Steven R Feldman, Madhuri Ventrapragada, et al.Cutis|July 1, 1994
Microscopic artifact found during examination of the skin: plant hair of Viburnum dentatumA B Fleischer, M Stonecipher, K A Kron, et al.Journal of Drugs in Dermatology : JDD|September 5, 2013
Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%Stefan Plaum, Amit Verma, Alan B Fleischer, et al.Human Genetics|June 1, 1989
Molecular cloning of the translocation breakpoint in T-ALL 11;14 (p13;q11): genomic map of TCR alpha and delta region on chromosome 14q11 and long-range map of region 11p13B Royer-Pokora, B Fleischer, S Ragg, et al.Journal of Drugs in Dermatology : JDD|December 21, 2020
Time Intervals Until the First Return Office Visit After New MedicationsSuraj Muddasani, Courtney E Heron, Alan B Fleischer, et al.Journal of the American Academy of Dermatology|September 25, 1999
Significance-prevalence index number: a reinterpretation and enhancement of data from the North American contact dermatitis groupM Maouad, A B Fleischer, E F Sherertz, et al.Journal of Cutaneous Medicine and Surgery|September 26, 2000
Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotrieneS R Feldman, S Sahu, A B Fleischer, et al.Experimental Hematology|February 1, 1993
Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndromeH Schrezenmeier, S D Thomé, F Tewald, et al.Pageof 114